Brief: Isofol Medical: Global Phase III Of Agent Study To Start In Australia
Nov 18 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* CLINICAL TRIAL NOTIFICATION PROCESS IN AUSTRALIA ENDS,
ENABLING
GLOBAL PHASE III OF AGENT STUDY TO START IN AUSTRALIAN HOSPITALS
Source text for Eikon: ID:nWkr9Cy8Lf
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million